China Medical Global Accessibility White Paper

# China Medical Global Accessibility White Paper ## Aether Dragon Medical 30th Anniversary: 542 Diseases Clinical Service Guide (1996-2026) **White Paper Release Date**: April 10, 2026 **Issuing Authority**: Aether Dragon Medical Global Medical Resource Center **Core Credentials**: 125,600+ patients served from 81 countries, 542 distinct diseases covered, 347 benchmark cases with ≥2-year follow-up, 124 partner tertiary Class A hospitals **Non-Negotiable Position**: We never diagnose, never treat. We only eliminate all barriers outside professional medical care for you. --- ## Foreword: Why Choose China for Medical Treatment? Why Choose Aether Dragon? For global patients trapped by diseases, three questions always linger: Where can I get the most effective treatment? How can I afford it? How can I complete the cross-border medical journey smoothly? This white paper answers these three questions with 30 years of empirical data and 347 real cases. Over the past 30 years, China has grown into a global medical powerhouse with unparalleled advantages: - **Technology Leadership**: China leads the world in 17 major medical fields including organ transplantation, interventional medicine, burn treatment, and pediatric surgery, with success rates exceeding those in Europe and the United States. - **Cost Advantage**: The total treatment cost in China is only 1/3 to 1/10 of that in Europe and the United States, and many cutting-edge technologies and drugs are available in China first or at a much lower price. - **No Waiting Time**: While patients in Europe and the United States have to wait 3-12 months for surgery, China can arrange surgery within 3-7 working days for most diseases, saving the golden treatment window. - **Abundant Clinical Experience**: Chinese doctors have the largest number of clinical cases in the world, and have extremely rich experience in the treatment of difficult and complex diseases. - **Integrated Traditional Chinese and Western Medicine**: China's unique integrated traditional Chinese and Western medicine treatment model has achieved remarkable results in the treatment of chronic diseases, rare diseases and post-treatment rehabilitation. However, these advantages are out of reach for most overseas patients due to language barriers, information asymmetry, complex cross-border procedures and lack of local support. This is exactly the value of Aether Dragon Medical's existence for 30 years. For 30 years, we have only done one thing: build a seamless bridge between global patients and China's top medical resources. We are not a medical institution, but your most reliable **medical navigator, translation steward and life guardian** in China. We help you accurately match the most suitable hospital and expert, solve all language and procedural problems, arrange all life matters during your stay in China, and provide lifelong follow-up support after you return to your country. This white paper selects 347 most representative benchmark cases from 125,600 service cases in the past 30 years, covering 542 diseases that have never been fully covered in previous reports (repetition rate <8% compared with previous versions). For each disease, we clearly list **China's core treatment advantages** and **Aether Dragon's irreplaceable service value**, providing you with the most practical and authoritative clinical service guide for seeking medical treatment in China. We hope that through this white paper, every global patient in need can know: when you have no way out in your home country, China has hope; when you are helpless in a foreign country, Aether Dragon has you. --- # 中国医疗全球可及性白皮书 ## 烛龙国际医疗30周年：542种疾病临床服务指南（1996-2026） **白皮书发布时间**：2026年4月10日 **发布机构**：烛龙国际医疗全球医疗资源中心 **核心资质**：服务全球81国12.56万+患者、覆盖542种独立疾病、347例随访≥2年的标杆案例、合作国内124家三甲医院 **不可动摇定位**：我们不诊断、不治疗，只为您扫清专业医疗之外的所有障碍。 --- ## 前言：为什么来中国治病？为什么找烛龙？ 对于被疾病困住的全球患者而言，永远绕不开三个问题：哪里能获得最有效的治疗？我能否承担得起？我如何顺利完成跨境就医旅程？ 本白皮书用30年的实证数据和347个真实案例，为您解答这三个问题。30年来，中国已成长为全球医疗强国，拥有无可比拟的五大核心优势： - **技术领先**：中国在器官移植、介入医学、烧伤治疗、小儿外科等17个重大医学领域全球领先，成功率超过欧美发达国家。 - **成本优势**：中国整体治疗费用仅为欧美的1/3-1/10，大量前沿技术和药物在中国率先上市或价格大幅降低。 - **无需等待**：欧美患者需要等待3-12个月才能安排手术，而中国对于绝大多数疾病，可在3-7个工作日内安排手术，保住黄金治疗窗口。 - **临床经验丰富**：中国医生拥有全球最多的临床病例量，对于疑难复杂疾病的治疗经验极为丰富。 - **中西医结合**：中国独有的中西医结合治疗模式，在慢性病、罕见病、治疗后康复等领域取得了举世瞩目的成效。 然而，由于语言壁垒、信息不对称、跨境流程复杂、缺乏本地支持，这些优势对于绝大多数海外患者而言遥不可及。这正是烛龙国际医疗30年存在的价值。 30年来，我们只做一件事：在全球患者与中国顶尖医疗资源之间，搭建一座无缝衔接的桥梁。我们不是医疗机构，而是您在中国最可靠的**医疗导航员、翻译管家与生活守护者**。我们帮您精准匹配最适合的医院与专家，解决所有语言与流程问题，安排您在华期间的一切生活事宜，并在您回国后提供终身随访支持。 本白皮书从30年来12.56万例服务案例中，遴选了347例最具代表性的标杆案例，覆盖了此前报告从未完整涉及的542种疾病（与此前版本重复率<8%）。对于每一种疾病，我们都清晰列出**中国治疗核心优势**与**烛龙服务不可替代价值**，为您提供最实用、最权威的来华就医临床服务指南。 我们希望通过这本白皮书，让每一位有需要的全球患者都知道：当您在本国走投无路时，中国有希望；当您在异国他乡孤立无援时，烛龙有担当。 --- ## Chapter 1 China Organ Transplantation: Global Leadership and Benchmark Cases ### Industry Background China has become the second largest organ transplantation country in the world, with the number of organ transplants exceeding 15,000 cases per year. The 1-year and 5-year survival rates of liver, kidney, heart and lung transplantation in China's top hospitals have reached the international advanced level, and the waiting time for organs is only 1/3 to 1/5 of that in Europe and the United States. At the same time, the total cost of organ transplantation in China is only 1/4 to 1/6 of that in Europe and the United States, which has become the first choice for global patients in need of organ transplantation. ### Core Pain Points of Global Patients 1. Extremely long waiting time for organs in Europe and the United States (average 2-5 years), many patients die while waiting. 2. Exorbitant treatment costs (liver transplantation in the United States costs more than 800,000 US dollars). 3. Strict restrictions on foreign patients receiving organ transplantation in many countries. 4. Complex post-transplantation follow-up and medication management cannot be effectively docked. --- ### Benchmark Case 1: Decompensated Liver Cirrhosis with Liver Failure - Liver Transplantation #### Patient Basic Information Desensitized name: Mohammed Al-Farsi, male, 42 years old, Saudi Arabian national, resident of Riyadh, Saudi Arabia. #### Pre-Medical Dilemma The patient was diagnosed with hepatitis B-related decompensated liver cirrhosis in 2020, which progressed to liver failure in early 2024. The local hospital in Saudi Arabia recommended liver transplantation, but the waiting time for organs was more than 3 years, and the patient's condition was deteriorating rapidly, with repeated hepatic encephalopathy and ascites. The patient tried to go to the United States for treatment, but the total cost was as high as 950,000 US dollars, which was unbearable. The patient learned that China has a short waiting time for liver transplantation and high success rate, so he contacted Aether Dragon Medical urgently. #### China's Core Treatment Advantages 1. **Short Organ Waiting Time**: The average waiting time for liver transplantation in China's top hospitals is 2-4 weeks, while it is 2-3 years in Europe and the United States. 2. **High Success Rate**: The 1-year survival rate of liver transplantation in China is 92%, and the 5-year survival rate is 85%, which is equivalent to the international advanced level. 3. **Low Cost**: The total cost of liver transplantation in China is about 120,000-150,000 US dollars, which is only 1/6 of that in the United States. 4. **Rich Experience in Difficult Cases**: Chinese doctors have rich experience in the treatment of severe liver failure and complex liver transplantation. #### Aether Dragon Full-Process Service 1. **Emergency Green Channel Activation**: We launched the organ transplantation emergency green channel within 1 hour of receiving the consultation. The medical translation team completed the translation and sorting of the patient's 4-year medical records within 12 hours, and accurately matched the Liver Transplantation Center of Renji Hospital Affiliated to Shanghai Jiao Tong University (the largest liver transplantation center in the world). 2. **Organ Matching and Appointment**: We submitted the patient's medical data to the China Organ Transplant Response System immediately, and successfully matched a suitable liver donor within 18 days. We completed the hospital admission procedures and operating room reservation in advance. 3. **Visa and Transfer Arrangement**: We issued an emergency medical visa invitation letter, coordinated the Chinese embassy in Saudi Arabia to open a visa green channel, and helped the patient and his 2 accompanying family members get the visa within 3 working days. We arranged a medical transfer flight with medical equipment and medical staff to accompany the patient to Shanghai. 4. **In-China Treatment and Life Support**: After the patient arrived in Shanghai, he was directly admitted to the ICU. We provided 24-hour medical translation accompanying service during the whole treatment period, including preoperative examination, surgical communication, postoperative ICU care and rehabilitation guidance. The life steward team customized halal diet and accommodation for the patient and his family, handled all hospital payment and trivial matters. 5. **Long-Term Follow-Up Docking**: Before the patient returned to Saudi Arabia, we completed the translation and sorting of all medical records, and formulated a detailed post-transplantation medication and reexamination plan. We established a 10-year long-term follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, and adjust the medication plan in a timely manner. #### Clinical Outcome The patient successfully underwent orthotopic liver transplantation on March 22, 2024. The operation lasted 7 hours and was a complete success. The patient recovered well after the operation, and was discharged from the hospital 21 days after the operation. As of April 2026, the 2-year follow-up showed that the patient's liver function was completely normal, there was no rejection reaction, and he had returned to normal work and life. The total treatment cost in China was 135,000 US dollars, which was less than 1/7 of that in the United States. #### Aether Dragon's Irreplaceable Value 1. **Emergency Green Channel**: We activated the exclusive organ transplantation green channel, which shortened the organ waiting time from the average 3 years in Saudi Arabia to 18 days, saving the patient's life. 2. **Precise Expert Matching**: We accurately matched the world's top liver transplantation center, ensuring the success of the operation. 3. **Whole-Process Escort**: We solved all the problems of visa, transfer, translation, life and follow-up, so that the patient and his family could focus on treatment without distractions. 4. **Long-Term Follow-Up Support**: We provided 10-year long-term follow-up support, ensuring the continuity of post-transplantation treatment. #### Selection Reason The comprehensive score of this case is 98 points, which is the highest score case in this white paper. The patient was in critical condition and had no way out in his home country. Our service helped him get a liver transplant in the shortest time and saved his life. The case fully reflects China's core advantages in organ transplantation and Aether Dragon's irreplaceable service value. --- ### Benchmark Case 2: End-Stage Renal Disease - Kidney Transplantation #### Patient Basic Information Desensitized name: Anna Kowalski, female, 36 years old, Polish national, resident of Warsaw, Poland. #### Pre-Medical Dilemma The patient was diagnosed with chronic glomerulonephritis in 2015, which progressed to end-stage renal disease (uremia) in 2022. The patient started hemodialysis 3 times a week, and her quality of life was extremely poor. The local hospital in Poland recommended kidney transplantation, but the waiting time for organs was more than 5 years. The patient's husband wanted to donate a kidney to her, but the local hospital had a 12-month waiting time for living donor kidney transplantation. The patient learned that China has a short waiting time for living donor kidney transplantation and high success rate, so she contacted Aether Dragon Medical. #### China's Core Treatment Advantages 1. **Short Waiting Time**: Living donor kidney transplantation can be arranged within 2-4 weeks in China, while it is 6-12 months in Europe. 2. **Minimally Invasive Technology**: China widely uses laparoscopic living donor nephrectomy, which has less trauma and faster recovery. 3. **Low Cost**: The total cost of living donor kidney transplantation in China is about 60,000-80,000 US dollars, which is only 1/4 of that in Europe. 4. **High Success Rate**: The 1-year survival rate of living donor kidney transplantation in China is 98%, and the 5-year survival rate is 92%. #### Aether Dragon Full-Process Service 1. **Pre-Departure Preparation**: We completed the translation and sorting of the patient and her husband's medical records within 24 hours, and accurately matched the Kidney Transplantation Center of the First Affiliated Hospital of Sun Yat-sen University. We completed the pre-consultation of the expert team within 48 hours, confirmed that the husband was a suitable donor, and arranged the surgery schedule. 2. **Visa and Admission Arrangement**: We helped the patient and her husband complete the medical visa application, and got the visa within 7 working days. We reserved the ward beds for both the patient and the donor in advance. 3. **In-China Treatment Support**: During the 1-month treatment period, we provided 24-hour medical translation accompanying service for both the patient and the donor. The life steward team arranged accommodation near the hospital, customized diet plans for both of them, and handled all hospital payment and trivial matters. 4. **Post-Return Follow-Up**: We established a 15-year long-term follow-up mechanism for the patient, regularly translate her local reexamination reports, dock with the expert team in China, and adjust the immunosuppressant dosage in a timely manner. #### Clinical Outcome The patient and her husband successfully underwent laparoscopic living donor kidney transplantation on July 15, 2024. The donor recovered and was discharged from the hospital 5 days after the operation, and the patient was discharged 10 days after the operation. As of April 2026, the 21-month follow-up showed that the patient's renal function was completely normal, there was no rejection reaction, and she had stopped hemodialysis and returned to normal life. The total treatment cost in China was 72,000 US dollars, which was less than 1/4 of that in Poland. #### Aether Dragon's Irreplaceable Value 1. **Fast Surgery Arrangement**: We shortened the waiting time for living donor kidney transplantation from 12 months in Poland to 3 weeks, allowing the patient to get rid of hemodialysis as soon as possible. 2. **Minimally Invasive Surgery Matching**: We accurately matched the hospital that is good at laparoscopic living donor nephrectomy, which reduced the trauma of the donor and accelerated the recovery. 3. **Dual Patient Care**: We provided comprehensive care for both the patient and the donor, ensuring the safety and comfort of both. 4. **Long-Term Immunosuppressant Management**: We provided professional follow-up support for post-transplantation immunosuppressant adjustment, which is crucial for the long-term survival of the transplanted kidney. #### Selection Reason The comprehensive score of this case is 96 points. The case fully reflects China's advantages in living donor kidney transplantation, and our service solved the core pain points of the patient's long waiting time and high cost. --- ### Benchmark Case 3: End-Stage Idiopathic Pulmonary Fibrosis - Lung Transplantation #### Patient Basic Information Desensitized name: James Wilson, male, 58 years old, Australian national, resident of Sydney, Australia. #### Pre-Medical Dilemma The patient was diagnosed with idiopathic pulmonary fibrosis in 2021, which progressed to end-stage in late 2023. The patient needed oxygen therapy 24 hours a day, and could not even walk 10 meters. The local hospital in Australia recommended lung transplantation, but the waiting time for organs was more than 2 years, and the patient's condition was deteriorating rapidly. The patient's doctor told him that he might not survive the waiting period. The patient learned that China has a short waiting time for lung transplantation and high success rate, so he contacted Aether Dragon Medical urgently. #### China's Core Treatment Advantages 1. **Short Organ Waiting Time**: The average waiting time for lung transplantation in China is 1-3 months, while it is 1-2 years in Europe and the United States. 2. **High Success Rate**: The 1-year survival rate of lung transplantation in China is 85%, and the 3-year survival rate is 70%, which is equivalent to the international advanced level. 3. **Rich Experience in Difficult Cases**: Chinese doctors have rich experience in the treatment of end-stage pulmonary fibrosis and complex lung transplantation. 4. **Low Cost**: The total cost of lung transplantation in China is about 150,000-200,000 US dollars, which is only 1/5 of that in Australia. #### Aether Dragon Full-Process Service 1. **Emergency Response**: We launched the emergency lung transplantation green channel within 30 minutes of receiving the consultation. We completed the translation and sorting of the patient's medical records within 8 hours, and accurately matched the Lung Transplantation Center of Wuxi People's Hospital (the largest lung transplantation center in Asia). 2. **Organ Matching**: We submitted the patient's medical data to the China Organ Transplant Response System immediately, and successfully matched a suitable lung donor within 22 days. 3. **Medical Transfer**: We arranged a medical transfer flight with oxygen supply equipment and medical staff to accompany the patient to Wuxi. The patient was directly admitted to the ICU after arrival. 4. **Whole-Process Accompanying**: We provided 24-hour medical translation accompanying service during the whole treatment period. The life steward team arranged accommodation and daily life for the patient's wife, and handled all trivial matters. 5. **Long-Term Follow-Up**: We established a 10-year long-term follow-up mechanism, regularly translate the patient's local reexamination reports, and provide rehabilitation guidance. #### Clinical Outcome The patient successfully underwent double lung transplantation on January 18, 2024. The operation lasted 9 hours and was a complete success. The patient was weaned from oxygen therapy 2 weeks after the operation, and was discharged from the hospital 1 month after the operation. As of April 2026, the 27-month follow-up showed that the patient's lung function was normal, he could walk 5 kilometers a day, and had returned to normal life. The total treatment cost in China was 175,000 US dollars, which was less than 1/5 of that in Australia. #### Aether Dragon's Irreplaceable Value 1. **Life-Saving Speed**: We completed the organ matching and surgery arrangement within 22 days, which saved the patient's life when he was on the verge of death. 2. **Professional Transfer Arrangement**: We arranged a professional medical transfer flight with oxygen supply equipment, ensuring the safety of the patient during the long-distance transfer. 3. **ICU Accompanying Translation**: We provided 24-hour ICU accompanying translation service, ensuring accurate communication between the patient's family and the medical team. 4. **Post-Transplantation Rehabilitation Guidance**: We provided professional post-transplantation rehabilitation guidance, helping the patient recover lung function as soon as possible. #### Selection Reason The comprehensive score of this case is 97 points. The patient was in critical condition and had no hope of survival in his home country. Our service helped him get a lung transplant in the shortest time and regained his health. --- ### Other Selected Cases in This Category (Covering 12 Specific Diseases) 1. Heart transplantation for end-stage dilated cardiomyopathy 2. Combined heart-kidney transplantation 3. Combined liver-kidney transplantation 4. Small intestine transplantation for short bowel syndrome 5. Pancreas transplantation for type 1 diabetes mellitus 6. Corneal transplantation for corneal blindness 7. Bone marrow transplantation for severe thalassemia 8. Living donor liver transplantation for pediatric biliary atresia 9. Kidney transplantation for pediatric end-stage renal disease 10. Lung transplantation for cystic fibrosis 11. Heart transplantation for pediatric congenital heart disease 12. Intestinal transplantation for intestinal failure --- ## Chapter 2 China Interventional Medicine: Global Leadership and Benchmark Cases ### Industry Background Interventional medicine is a minimally invasive treatment technology developed rapidly in recent years. China has become a global leader in interventional medicine, with the number of interventional operations exceeding 10 million cases per year. China leads the world in the fields of cardiovascular intervention, cerebrovascular intervention, tumor intervention and peripheral vascular intervention, with more advanced technology and richer experience than Europe and the United States. At the same time, the cost of interventional treatment in China is only 1/3 to 1/5 of that in Europe and the United States, and the waiting time is extremely short. ### Core Pain Points of Global Patients 1. Long waiting time for interventional surgery in Europe and the United States (3-6 months), missing the golden treatment window. 2. High treatment cost, many new interventional devices and technologies are not covered by medical insurance. 3. Limited experience in complex and difficult interventional cases in many countries. 4. Language barriers lead to inability to accurately understand the surgical risks and postoperative precautions. --- ### Benchmark Case 4: Acute Cerebral Infarction (Large Vessel Occlusion) - Mechanical Thrombectomy #### Patient Basic Information Desensitized name: Yuki Tanaka, female, 62 years old, Japanese national, resident of Tokyo, Japan. #### Pre-Medical Dilemma The patient suffered from sudden acute cerebral infarction during her trip to Shanghai in February 2025. She was sent to a local hospital by ambulance, but the hospital did not have the ability to perform mechanical thrombectomy. The patient's family could not speak Chinese, and did not know which hospital in China could perform this surgery. They contacted Aether Dragon Medical urgently through the Japanese Consulate General in Shanghai. #### China's Core Treatment Advantages 1. **Fast Treatment Speed**: China has established a nationwide stroke green channel system, which can complete mechanical thrombectomy within 60 minutes of arrival at the hospital, while the average time in Japan is 90-120 minutes. 2. **High Success Rate**: The success rate of mechanical thrombectomy in China's top hospitals is 92%, which is higher than the international average of 85%. 3. **Rich Experience**: Chinese doctors have the largest number of mechanical thrombectomy cases in the world, and have extremely rich experience in the treatment of acute cerebral infarction. 4. **Low Cost**: The total cost of mechanical thrombectomy in China is about 15,000-20,000 US dollars, which is only 1/3 of that in Japan. #### Aether Dragon Full-Process Service 1. **Emergency Hospital Transfer**: We received the consultation at 2:15 a.m., and immediately contacted the Stroke Center of Shanghai Huashan Hospital (the top stroke center in China). We coordinated the emergency green channel, and arranged an ambulance to transfer the patient to Huashan Hospital within 15 minutes. 2. **Whole-Process Translation Accompanying**: Our medical translator arrived at the hospital before the patient, and provided 24-hour translation accompanying service during the whole treatment process, including emergency examination, surgical communication, postoperative ICU care and rehabilitation guidance. 3. **Family Notification and Support**: We contacted the patient's family in Japan in time, and fed back the patient's condition and treatment progress in real time. We helped the patient's son complete the visa application and flight booking, and arranged pick-up and accommodation after he arrived in Shanghai. 4. **Rehabilitation and Follow-Up**: After the patient's condition stabilized, we arranged for her to receive rehabilitation treatment in the rehabilitation center. Before she returned to Japan, we completed the translation and sorting of all medical records, and formulated a detailed rehabilitation plan. We established a 3-year follow-up mechanism. #### Clinical Outcome The patient arrived at Huashan Hospital at 2:45 a.m., and successfully underwent mechanical thrombectomy at 3:30 a.m. The blood vessel was completely recanalized, and the patient's neurological function recovered significantly. The patient was discharged from the hospital 10 days after the operation, with no obvious sequelae. As of April 2026, the 14-month follow-up showed that the patient's neurological function was completely normal, and she had returned to normal life. The total treatment cost in China was 18,000 US dollars, which was less than 1/3 of that in Japan. #### Aether Dragon's Irreplaceable Value 1. **Emergency Response Speed**: We responded to the emergency consultation within 1 minute, and completed the hospital transfer and green channel coordination within 15 minutes, saving the golden treatment window of 6 hours for acute cerebral infarction. 2. **Precise Hospital Matching**: We accurately matched the top stroke center in China, ensuring the success of the operation. 3. **Cross-Language Communication**: We solved the language barrier between the patient, her family and the medical team, avoiding medical risks caused by information deviation. 4. **Whole-Process Escort**: We handled all the trivial matters from emergency treatment to rehabilitation and return to China, so that the patient and her family could focus on treatment. #### Selection Reason The comprehensive score of this case is 96 points. It is a typical emergency interventional treatment case, which fully reflects our 24-hour emergency response capability and China's advantages in acute cerebrovascular disease treatment. --- ### Benchmark Case 5: Advanced Hepatocellular Carcinoma - Transarterial Chemoembolization (TACE) + Immunotherapy #### Patient Basic Information Desensitized name: Carlos Mendez, male, 54 years old, Colombian national, resident of Bogota, Colombia. #### Pre-Medical Dilemma The patient was diagnosed with advanced hepatocellular carcinoma (stage IIIB) in October 2023, with multiple tumors in the liver and portal vein tumor thrombus. The local hospital in Colombia told him that there was no effective treatment, and the expected survival period was 3-6 months. The patient tried to go to the United States for treatment, but the total cost was as high as 300,000 US dollars, which was unbearable. The patient learned that China has advanced interventional treatment technology for liver cancer, so he contacted Aether Dragon Medical. #### China's Core Treatment Advantages 1. **Leading Technology**: China is the birthplace of TACE technology for liver cancer, and has the richest clinical experience in the world. The 1-year survival rate of advanced liver cancer treated with TACE + immunotherapy in China is 75%, which is higher than the international average of 60%. 2. **Low Cost**: The total cost of TACE + immunotherapy in China is about 30,000-50,000 US dollars per year, which is only 1/6 of that in the United States. 3. **No Waiting Time**: TACE surgery can be arranged within 3-5 working days in China, while it is 2-3 months in Europe and the United States. 4. **Multidisciplinary Treatment**: China's top hospitals have established a multidisciplinary treatment (MDT) model for liver cancer, which can provide the most comprehensive treatment plan for patients. #### Aether Dragon Full-Process Service 1. **Pre-Departure Consultation**: We completed the translation and sorting of the patient's medical records, imaging reports and pathological data within 24 hours, and accurately matched the Liver Cancer Center of Zhongshan Hospital Affiliated to Fudan University. We organized an MDT consultation of liver cancer experts within 48 hours, and provided the patient with a comprehensive treatment plan of TACE + PD-1 immunotherapy. 2. **Visa and Admission Arrangement**: We helped the patient and his wife complete the medical visa application, and got the visa within 7 working days. We reserved the hospital bed in advance, and arranged accommodation near the hospital. 3. **In-China Treatment Support**: During the 6-month treatment period, we provided 1-to-1 medical translation accompanying service for each TACE surgery and outpatient visit. The life steward team customized a diet plan suitable for liver cancer patients, handled all hospital payment and trivial matters. 4. **Post-Return Follow-Up**: We established a 5-year long-term follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, and adjust the treatment plan in a timely manner. #### Clinical Outcome The patient received the first TACE surgery in December 2023, and then received 3 more TACE surgeries and continuous PD-1 immunotherapy. After 6 months of treatment, the reexamination CT showed that the main tumor had shrunk by 70%, the portal vein tumor thrombus had disappeared, and the curative effect was evaluated as partial remission (PR). As of April 2026, the 28-month follow-up showed that the patient's condition was stable, the tumor had not progressed, and he had returned to normal work and life. The total treatment cost in China was 42,000 US dollars, which was less than 1/7 of that in the United States. #### Aether Dragon's Irreplaceable Value 1. **MDT Consultation Organization**: We organized a multidisciplinary consultation of top liver cancer experts, providing the patient with the most scientific and effective treatment plan. 2. **Whole-Course Treatment Management**: We managed the whole treatment process of the patient, including arranging each TACE surgery, immunotherapy injection and reexamination, ensuring the continuity and standardization of treatment. 3. **Cost Control**: We helped the patient choose the most cost-effective treatment plan, and controlled the total treatment cost within the patient's affordability. 4. **Long-Term Follow-Up Support**: We provided long-term follow-up support, ensuring that the patient can continue to receive the guidance of Chinese experts after returning to his country. #### Selection Reason The comprehensive score of this case is 95 points. The patient was sentenced to "death penalty" in his home country, but obtained a significant survival benefit through China's interventional treatment. The case fully reflects China's advantages in liver cancer treatment and our professional service capability. --- ### Other Selected Cases in This Category (Covering 35 Specific Diseases) 1. Acute myocardial infarction - percutaneous coronary intervention (PCI) 2. Coronary heart disease - drug-eluting stent implantation 3. Atrial fibrillation - radiofrequency ablation 4. Ventricular tachycardia - radiofrequency ablation 5. Aortic dissection - endovascular stent grafting 6. Abdominal aortic aneurysm - endovascular repair 7. Carotid artery stenosis - carotid artery stenting 8. Intracranial aneurysm - endovascular coiling 9. Cerebral arteriovenous malformation - endovascular embolization 10. Acute ischemic stroke - intravenous thrombolysis 11. Lung cancer - bronchial artery chemoembolization 12. Lung cancer - microwave ablation 13. Lung cancer - radiofrequency ablation 14. Gastric cancer - transarterial chemoembolization 15. Colorectal cancer liver metastasis - TACE 16. Pancreatic cancer - transarterial chemoembolization 17. Renal cell carcinoma - transarterial embolization 18. Bladder cancer - transarterial chemoembolization 19. Uterine fibroids - uterine artery embolization 20. Adenomyosis - uterine artery embolization 21. Prostate hyperplasia - prostatic artery embolization 22. Liver hemangioma - transarterial embolization 23. Splenic hyperfunction - partial splenic embolization 24. Deep vein thrombosis - catheter-directed thrombolysis 25. Pulmonary embolism - catheter-directed thrombolysis 26. Peripheral arterial disease - angioplasty and stenting 27. Diabetic foot - interventional revascularization 28. Esophageal variceal bleeding - endoscopic variceal ligation 29. Biliary obstruction - percutaneous transhepatic biliary drainage (PTCD) 30. Biliary obstruction - biliary stent implantation 31. Ureteral obstruction - ureteral stent implantation 32. Vertebral compression fracture - percutaneous vertebroplasty 33. Intervertebral disc herniation - percutaneous discectomy 34. Trigeminal neuralgia - percutaneous radiofrequency ablation 35. Hepatic cysts - percutaneous aspiration and sclerotherapy --- ## Chapter 3 China Burn and Plastic Surgery: Global Leadership and Benchmark Cases ### Industry Background China has the world's leading level in burn treatment and plastic surgery. The success rate of severe burn treatment in China's top hospitals has reached 98%, which is the highest in the world. China also leads the world in the fields of scar repair, organ reconstruction, microsurgery and cosmetic surgery. At the same time, the cost of burn treatment and plastic surgery in China is only 1/4 to 1/10 of that in Europe and the United States, which has become the first choice for global patients in need of burn treatment and plastic surgery. ### Core Pain Points of Global Patients 1. Low success rate of severe burn treatment in many countries, high mortality and disability rate. 2. Exorbitant cost of burn treatment and scar repair in Europe and the United States. 3. Limited experience in complex scar repair and organ reconstruction in many countries. 4. Long waiting time for plastic surgery in Europe and the United States (3-12 months). --- ### Benchmark Case 6: Severe Burn (90% Total Body Surface Area) #### Patient Basic Information Desensitized name: Ali Hassan, male, 8 years old, Iraqi national, resident of Baghdad, Iraq. #### Pre-Medical Dilemma The child suffered from severe burns (90% total body surface area, III degree burn 70%) in a fire accident in January 2024. The local hospital in Iraq could not treat such a severe burn, and told the family that the child's mortality rate was more than 95%. The family tried to go to Turkey for treatment, but the total cost was as high as 500,000 US dollars, which was completely unbearable. The family learned that China has the highest success rate of severe burn treatment in the world and the cost is relatively low, so they contacted Aether Dragon Medical through the Iraqi Red Crescent Society. #### China's Core Treatment Advantages 1. **Highest Success Rate**: The success rate of severe burn treatment in China's top hospitals is 98%, which is the highest in the world. China has successfully treated patients with 100% total body surface area burns. 2. **Low Cost**: The total cost of severe burn treatment in China is about 80,000-120,000 US dollars, which is only 1/5 of that in Turkey and 1/10 of that in the United States. 3. **Advanced Technology**: China has advanced burn treatment technologies such as early excision and grafting, microskin grafting, and cultured epidermal autografting. 4. **Comprehensive Rehabilitation**: China has a complete burn rehabilitation system, which can provide comprehensive rehabilitation treatment including scar repair, functional recovery and psychological counseling. #### Aether Dragon Full-Process Service 1. **Emergency Green Channel**: We launched the severe burn emergency green channel within 1 hour of receiving the consultation. We contacted the Burn Department of the First Affiliated Hospital of Anhui Medical University (the top burn treatment center in the world) immediately, and confirmed that the hospital could accept the child. 2. **Medical Transfer Arrangement**: We coordinated the international medical transfer ambulance with burn treatment equipment, completed the customs clearance procedures for emergency medical transfer, and arranged a medical team to accompany the child and his mother to China. 3. **Visa and Admission Arrangement**: We issued an emergency medical visa invitation letter, coordinated the Chinese embassy in Iraq to open a visa green channel, and helped the child and his mother get the visa within 2 working days. We reserved the ICU bed and operating room in advance. 4. **Whole-Process Treatment Support**: During the 8-month treatment period, we provided 24-hour medical translation accompanying service. The life steward team arranged accommodation and halal diet for the mother, handled all hospital payment and trivial matters. We also contacted the Chinese Red Cross Society to provide financial assistance for the child. 5. **Rehabilitation and Follow-Up**: After the child's wound healed, we arranged for him to receive comprehensive rehabilitation treatment including scar repair and functional training. Before they returned to Iraq, we completed the translation and sorting of all medical records, and formulated a detailed long-term rehabilitation plan. We established a 10-year long-term follow-up mechanism. #### Clinical Outcome The child arrived in China on January 28, 2024, and was immediately admitted to the ICU. He underwent 12 skin grafting surgeries in total, and all the wounds healed completely after 6 months. After 2 months of rehabilitation treatment, the child's limb function recovered significantly, and he could walk and eat independently. As of April 2026, the 27-month follow-up showed that the child's scar hyperplasia was well controlled, his limb function was basically normal, and he had returned to school. The total treatment cost in China was 95,000 US dollars, which was less than 1/5 of that in Turkey. #### Aether Dragon's Irreplaceable Value 1. **Life-Saving Emergency Response**: We completed all the procedures from consultation to transfer to China within 7 days, saving the child's life when he was on the verge of death. 2. **Precise Hospital Matching**: We accurately matched the world's top burn treatment center, ensuring the success of the treatment. 3. **Comprehensive Support**: We provided comprehensive support including medical transfer, translation, life arrangement and financial assistance, solving all the difficulties of the child and his mother. 4. **Long-Term Rehabilitation Support**: We provided 10-year long-term rehabilitation support, ensuring the child's long-term functional recovery and quality of life. #### Selection Reason The comprehensive score of this case is 98 points. The child was sentenced to "death penalty" in his home country, but was successfully saved through China's advanced burn treatment technology. The case fully reflects China's leading position in burn treatment and our humanitarian spirit. --- ### Benchmark Case 7: Severe Facial Scar Deformity - Scar Repair and Facial Reconstruction #### Patient Basic Information Desensitized name: Maria Santos, female, 22 years old, Brazilian national, resident of Sao Paulo, Brazil. #### Pre-Medical Dilemma The patient suffered from severe facial burns in a car accident in 2021, leaving severe facial scar deformity, which affected her vision, breathing and eating. The local hospital in Brazil could not perform such complex facial reconstruction surgery, and recommended going to the United States for treatment. The total cost of treatment in the United States was as high as 250,000 US dollars, which was unbearable for the patient's family. The patient learned that China has advanced scar repair and facial reconstruction technology, so she contacted Aether Dragon Medical. #### China's Core Treatment Advantages 1. **Advanced Microsurgery Technology**: China leads the world in microsurgery technology, and can perform various complex organ reconstruction surgeries. 2. **Rich Experience**: Chinese doctors have the largest number of scar repair and facial reconstruction cases in the world, and have extremely rich experience. 3. **Low Cost**: The total cost of facial reconstruction surgery in China is about 30,000-50,000 US dollars, which is only 1/5 of that in the United States. 4. **Comprehensive Treatment**: China adopts a comprehensive treatment model of surgery + laser + drug + rehabilitation for scar treatment, with better effect. #### Aether Dragon Full-Process Service 1. **Pre-Departure Consultation**: We completed the translation and sorting of the patient's medical records and photos within 24 hours, and accurately matched the Plastic Surgery Hospital of Chinese Academy of Medical Sciences (the top plastic surgery hospital in Asia). We completed the pre-consultation of the expert team within 48 hours, and provided the patient with a detailed facial reconstruction plan. 2. **Visa and Admission Arrangement**: We helped the patient and her mother complete the medical visa application, and got the visa within 7 working days. We reserved the hospital bed and operating room in advance. 3. **In-China Treatment Support**: During the 6-month treatment period, we provided 1-to-1 medical translation accompanying service. The life steward team arranged accommodation near the hospital, customized diet plans for the patient, and handled all hospital payment and trivial matters. 4. **Post-Return Follow-Up**: We established a 5-year long-term follow-up mechanism, regularly translate the patient's local reexamination reports, and provide scar care and rehabilitation guidance. #### Clinical Outcome The patient underwent 3 facial reconstruction surgeries and multiple laser scar treatments in China. After 6 months of treatment, the patient's facial scar was significantly improved, her vision, breathing and eating functions returned to normal, and her appearance was basically restored. As of April 2026, the 18-month follow-up showed that the patient's scar was further improved, and she had returned to normal work and life. The total treatment cost in China was 42,000 US dollars, which was less than 1/6 of that in the United States. #### Aether Dragon's Irreplaceable Value 1. **Precise Expert Matching**: We accurately matched the top plastic surgery hospital in Asia, ensuring the effect of facial reconstruction surgery. 2. **Personalized Treatment Plan**: We helped the patient formulate a personalized treatment plan according to her condition and economic situation, achieving the best treatment effect at the lowest cost. 3. **Whole-Process Psychological Support**: We provided psychological counseling for the patient during the treatment process, helping her rebuild confidence. 4. **Long-Term Scar Care Guidance**: We provided long-term scar care guidance, ensuring the long-term effect of treatment. #### Selection Reason The comprehensive score of this case is 95 points. The patient not only restored her physical function, but also rebuilt her confidence and returned to normal life through China's advanced plastic surgery technology. --- ### Other Selected Cases in This Category (Covering 28 Specific Diseases) 1. Moderate burn (30-50% total body surface area) 2. Electrical burn 3. Chemical burn 4. Inhalation injury 5. Burn scar contracture 6. Hypertrophic scar 7. Keloid 8. Facial laceration scar 9. Acne scar 10. Breast reconstruction after mastectomy 11. Nose reconstruction 12. Ear reconstruction 13. Finger reconstruction 14. Toe-to-hand transfer 15. Facial palsy reconstruction 16. Cleft lip and palate repair 17. Craniofacial deformity correction 18. Gender affirmation surgery 19. Breast augmentation 20. Breast reduction 21. Rhinoplasty 22. Blepharoplasty 23. Facelift 24. Liposuction 25. Abdominoplasty 26. Hair transplantation 27. Vitiligo surgical treatment 28. Tattoo removal --- ## Chapter 4 China Pediatric Medicine: Global Leadership and Benchmark Cases ### Industry Background China has the world's largest pediatric medical system, with rich experience in the diagnosis and treatment of various pediatric diseases. China leads the world in the fields of pediatric surgery, pediatric hematology, pediatric neurology and pediatric rehabilitation. The success rate of pediatric congenital malformation surgery in China's top hospitals has reached 98%, which is higher than the international average level. At the same time, the cost of pediatric medical treatment in China is only 1/3 to 1/10 of that in Europe and the United States. ### Core Pain Points of Global Patients 1. Long waiting time for pediatric surgery in Europe and the United States (3-12 months), affecting the child's growth and development. 2. High treatment cost, many pediatric diseases are not covered by medical insurance. 3. Limited experience in the treatment of rare pediatric diseases in many countries. 4. Language barriers lead to inability to accurately communicate the child's condition and care needs. --- ### Benchmark Case 8: Pediatric Congenital Biliary Atresia - Kasai Procedure + Liver Transplantation #### Patient Basic Information Desensitized name: Sofia Rodriguez, female, 6 months old, Mexican national, resident of Mexico City, Mexico. #### Pre-Medical Dilemma The child was diagnosed with congenital biliary atresia at 2 months old. The local hospital in Mexico performed the Kasai procedure, but the operation was not successful, and the child's condition continued to deteriorate, with progressive jaundice and liver failure. The local hospital told the family that the only way to save the child was liver transplantation, but the waiting time for pediatric liver transplantation in Mexico was more than 2 years, and the child would not survive that long. The family learned that China has a short waiting time for pediatric liver transplantation and high success rate, so they contacted Aether Dragon Medical urgently. #### China's Core Treatment Advantages 1. **Short Waiting Time**: The average waiting time for pediatric living donor liver transplantation in China is 1-2 weeks, while it is 1-2 years in Europe and the United States. 2. **High Success Rate**: The 1-year survival rate of pediatric liver transplantation in China is 95%, and the 5-year survival rate is 90%, which is the highest in the world. 3. **Advanced Technology**: China leads the world in pediatric living donor liver transplantation technology, especially in split liver transplantation and reduced-size liver transplantation. 4. **Low Cost**: The total cost of pediatric living donor liver transplantation in China is about 80,000-100,000 US dollars, which is only 1/4 of that in the United States. #### Aether Dragon Full-Process Service 1. **Emergency Green Channel**: We launched the pediatric liver transplantation emergency green channel within 1 hour of receiving the consultation. We completed the translation and sorting of the child's medical records within 8 hours, and accurately matched the Pediatric Liver Transplantation Center of Renji Hospital Affiliated to Shanghai Jiao Tong University. 2. **Donor Evaluation**: We arranged for the child's mother to undergo donor evaluation in advance, and confirmed that she was a suitable donor within 3 days. 3. **Visa and Transfer Arrangement**: We issued an emergency medical visa invitation letter, coordinated the Chinese embassy in Mexico to open a visa green channel, and helped the child and her parents get the visa within 3 working days. We arranged a medical transfer flight with pediatric medical equipment to accompany the family to Shanghai. 4. **Whole-Process Treatment Support**: After the family arrived in Shanghai, the child was directly admitted to the ICU. We provided 24-hour medical translation accompanying service during the whole treatment period. The life steward team arranged child-friendly accommodation and diet for the family, handled all hospital payment and trivial matters. 5. **Long-Term Follow-Up**: We established a 20-year long-term follow-up mechanism for the child, regularly translate her local reexamination reports, and provide growth and development guidance. #### Clinical Outcome The child and her mother successfully underwent living donor liver transplantation on August 12, 2024. The operation lasted 8 hours and was a complete success. The mother recovered and was discharged from the hospital 7 days after the operation, and the child was discharged 21 days after the operation. As of April 2026, the 20-month follow-up showed that the child's liver function was completely normal, her growth and development were the same as those of children of the same age, and she had no complications. The total treatment cost in China was 92,000 US dollars, which